Roberto Alfonso Accinelli (Roberto A Accinelli)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Extracorporeal Membrane Oxygenation

Respiratory Syndrome Coronavirus

Top Venues

Respirology (Carlton, Vic.)

Revista peruana de medicina experimental y salud publica

This page only lists publications with an associated author ORCID identifier.

Publications

Roberto Alfonso Accinelli, Seungseo Choi
Current challenges with control of multi-drug resistant TB in Peru: Lessons from the past and goals for the future. Respirology (Carlton, Vic.) (2024)
Roberto Alfonso Accinelli, Seungseo Choi
Current challenges with control of multi-drug resistant TB in Peru: Lessons from the past and goals for the future. Respirology (Carlton, Vic.) 29 (8) (2024)
Roberto Alfonso Accinelli
Letter from Peru: Why was Peru the country with the world's highest infection and death rates for SARS-CoV-2? Respirology (Carlton, Vic.) (2023)
Juan Alonso Leon-Abarca, Arianna Sibila Portmann Baracco, Mayte Bryce-Alberti, Carlos Ruiz-Sánchez, Roberto Alfonso Accinelli, Jorge Soliz, Gustavo Francisco Gonzales
Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients. PloS one 16 (8) (2021)
Roberto Alfonso Accinelli, Cristian Mingxiong Zhang Xu, Jia-Der Ju Wang, José Miguel Yachachin-Chávez, Jaime Augusto Cáceres-Pizarro, Karla Beatriz Tafur-Bances, Roberto Gabriel Flores-Tejada, Alejandra Del Carmen Paiva-Andrade
Revista peruana de medicina experimental y salud publica 37 (2) (2020)
Roberto Alfonso Accinelli, Juan Alonso Leon-Abarca
Age and altitude of residence determine anemia prevalence in Peruvian 6 to 35 months old children. PloS one 15 (1) (2020)
Roberto Alfonso Accinelli, Jorge Lam, Karla B Tafur
[The electronic cigarette: an emerging public health problem]. Revista peruana de medicina experimental y salud publica 37 (1) (2020)
Roberto Alfonso Accinelli, Alfredo Camposano
Revista peruana de medicina experimental y salud publica 37 (2) (2020)